• OPEN AN ACCOUNT
Indian Indices
Nifty
17,685.60 -252.80
(-1.41%)
Sensex
59,240.58 -858.24
( -1.43%)
Bank Nifty
37,675.25 -366.10
( -0.96%)
Nifty IT
36,596.55 -685.15
( -1.84%)
Global Indices
Nasdaq
14,340.26 -166.64
(-1.15%)
Dow Jones
35,028.65 -339.82
(-0.96%)
Hang Seng
24,952.35 824.50
(3.42%)
Nikkei 225
27,772.93 305.70
(1.11%)
Forex
USD-INR
74.40 0.00
(0.00%)
EUR-INR
84.35 -0.25
(-0.29%)
GBP-INR
101.29 0.00
(0.00%)
JPY-INR
0.65 0.00
(0.21%)

EQUITY - MARKET SCREENER

Taaza International Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
537392
INE392H01018
10.0141873
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
15.83
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

wipro ltd
Wipro introduces regulatory literature monitoring for pharmaceutical organizations
Dec 15,2021
Wipro has introduced regulatory literature monitoring for pharmaceutical organizations by entering a managed services engagement with Springer Nature.

Drug safety, referred to as Pharmacovigilance (PV), constitutes the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. PV departments in Life Sciences organizations, to fulfil drug safety requirements, leverage literature monitoring that includes Annual Reports, Periodic Safety Update Reports, Individual Case Study Report (ICSR) Monitoring, among others